Prenetics Reports Strong Q2 Earnings with Revenue Growth and Positive Cash Flow
Prenetics (PRE) delivered strong second-quarter results for fiscal year 2026, reporting total revenue of $46.5 million—up 3.9x from the prior year—and driven largely by its IM8 wellness brand, which contributed $45 million or 97% of overall sales. The company achieved a gross margin expansion to 65%, and for the first time in history, it turned positive on adjusted free cash flow in July. Despite continued losses—non-GAAP Adjusted EBITDA was -$19M due to heavy marketing investments—the firm raised its full-year revenue guidance from $210–$220 million to $220–$230 million and projected over $400 million for 2027. Prenetics also highlighted strong customer growth, acquiring nearly 118,500 new customers in Q2—up 98% sequentially—and reaching an annualized revenue run rate of approximately $251 million. The company’s unit economics improved significantly with a gross profit return of $1.52 for every dollar spent on acquisition and strong retention rates at month 20, outperforming key competitors like Thorne and AG1.
Tickers: $PRE
Topics: financials growth revenue